Correction to: “Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) Trial” - Top-Institutions - MDSpire

Correction to: “Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) Trial”

  • April 11, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    University of Melbourne
    University of Melbourne

    Melbourne, Victoria

    Key Differentiators

    • Endocrinology
    • Andrology
    • Clinical Trials

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Urology
    • Andrology

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Endocrinology
    • Andrology
    • Clinical Research

  • #4

    University of California, Los Angeles (UCLA)
    University of California, Los Angeles (UCLA)

    Los Angeles, California

    Key Differentiators

    • Endocrinology
    • Andrology
    • Urology

  • #5

    University of Sydney
    University of Sydney

    Sydney, New South Wales

    Key Differentiators

    • Endocrinology
    • Andrology

Original Source(s)

Correction to: “Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) Trial”

  • April 11, 2025

Related Content

Comparative study of the therapeutic effects of different medications on DM-associated dry eye syndrome after vitrectomy

Correlation between cardiorespiratory fitness and body composition in individuals with different glucose metabolism statuses

Prepregnancy Lipids Predict HDP Risk

A large Swedish cohort found cardiometabolic biomarkers measured up to decades before pregnancy were associated with hypertensive disorders — with risk apparent even below standard diagnostic thresholds.